Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Overactive Bladder (OAB): full-pipeline trial registry
7 of 8 indexed Overactive Bladder (OAB) trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 7 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Overactive Bladder (OAB): 8 US clinical trials tracked, 7 recruiting.
Overactive Bladder (OAB) is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is FemPulse Corporation, running 1 of these trials.
Enrollment posture brief
Registry condition overactive-bladder-oab
OPEN 7 | RECR 88% | LATE 1 | EARLY 1 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Diseases (88% recruiting · 8 trials)
Overactive Bladder (OAB) lists 7 open slots (88% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Overactive Bladder (OAB) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Overactive Bladder (OAB) is recruiting above its size-band peers.
7 of 8 indexed trials (87.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Overactive Bladder (OAB) trials is spread across many organizations.
FemPulse Corporation accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Overactive Bladder (OAB) enrolment sits around 151 participants.
Median target enrolment is 151 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Overactive Bladder (OAB) research is mostly interventional.
7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Medstar Health Research Institute
NCT06797245
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
InMode MD
NCT07209397
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
NCT07195656
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
Endeavor Health
NCT07405554
PMCF Study of the Axonics SNM System Model 5101 (R20)
Axonics
NCT06789406
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
Northwestern University
NCT06944392
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
Alexis Dieter
NCT07025044
Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
Astellas Pharma Global Development
NCT02216214
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Overactive Bladder (OAB) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Overactive Bladder (OAB) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Overactive Bladder (OAB) page
8 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Overactive Bladder (OAB) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- FemPulse Corporation sponsors the most Overactive Bladder (OAB) trials on record, review their full trial history before evaluating a specific study. See FemPulse Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Overactive Bladder (OAB) condition card totals 8 registered trials; most-linked intervention Placebo; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.